Codex DNA Inc. (DNAY)
NASDAQ: DNAY
· Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM
Codex DNA Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.75M | -31.57M | -46.4M | -48.47M | -80.86M | -50.34M | -44.71M | -38.96M | -32.05M | -26.69M | -21.57M |
Depreciation & Amortization | 1.01M | 945K | 1.59M | 1.67M | 3.05M | 1.42M | 1.14M | 908K | 1.46M | 1.45M | 1.45M |
Stock-Based Compensation | 1.04M | 3.32M | 4.43M | 3.73M | 4.55M | 2.44M | 1.47M | 1.09M | 587K | 231K | 95K |
Other Working Capital | -1.82M | -4.99M | -4.85M | 182K | 6.56M | 1.87M | 1.6M | -5.24M | 55K | 260K | 379K |
Other Non-Cash Items | 8.49M | 4.25M | 4.39M | 4.36M | 996K | 1.08M | 2.3M | 3.3M | 2.79M | 2.75M | 2.08M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.82M | -8.85M | -8.28M | n/a | 8.77M | 2.34M | 2.6M | -3.04M | -1.61M | 2.13M | 848K |
Operating Cash Flow | -4.38M | -31.91M | -44.26M | -38.72M | -63.49M | -43.06M | -37.2M | -36.7M | -28.82M | -20.13M | -17.11M |
Capital Expenditures | -168K | -1.62M | -4.48M | -4.47M | -8.38M | -5M | -2.21M | -1.85M | -588K | -263K | -293K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 2.57M | -19.24M | -39.16M | -77.43M | -136.85M | -65.35M | -45.42M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9.85M | 50.48M | 76.19M | 64.44M | 72.27M | 25.72M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.44M | -556K | -556K | -556K | -13.74M | -13.19M | -13.19M | -13.19M | n/a | n/a | n/a |
Investing Cash Flow | 13.7M | 29.06M | 32M | -18.01M | -86.7M | -57.81M | -60.82M | -15.04M | -588K | -263K | -293K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.63M | 4.1M | 4.43M | 4.51M | 4.78M | -611K | 111.55M | 121.08M | 121.08M | 122.04M | 9.52M |
Financial Cash Flow | -184K | 4.1M | 4.43M | 4.51M | 4.78M | -611K | 111.55M | 121.08M | 121.08M | 122.04M | 9.52M |
Net Cash Flow | n/a | 1.25M | -7.83M | -52.21M | -84.89M | -101.49M | 13.53M | 69.34M | 91.68M | 101.64M | -7.88M |
Free Cash Flow | -4.54M | -33.53M | -48.74M | -43.18M | -71.86M | -48.07M | -39.42M | -38.55M | -29.41M | -20.4M | -17.4M |